← FDA DRUG APPROVALS

FDA ANDA · ANDA205549

POTASSIUM CHLORIDE

Sponsor: STRIDES PHARMA

APPLICATION
ANDA205549
TYPE
ANDA
ORIGINAL APPROVAL
2015-12-08
LATEST ACTION
2025-04-21
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

POTASSIUM CHLORIDEDiscontinued
POTASSIUM CHLORIDE 10MEQ · CAPSULE, EXTENDED RELEASE · ORAL
POTASSIUM CHLORIDEDiscontinued
POTASSIUM CHLORIDE 8MEQ · CAPSULE, EXTENDED RELEASE · ORAL

Approval history

2025-04-21Labeling · Supplement 1 · standardAP
2015-12-08UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →